Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral Research

Affiliations

• ¹ Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: [email protected].
• ² Gilead Sciences, Inc., Foster City, CA, USA.
• ³ Evotec US, Princeton, NJ, USA.
• ⁴ Virus-Host Interactions & Therapeutic Approaches Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
• ⁵ Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD, Australia.
• ⁶ Centre International de Recherche en Infectiologie (CIRI), Inserm_U1111, CNRS_UMR5308, Université Claude Bernard Lyon 1, F-69007, Lyon, France.
• ⁷ Division of the Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
• ⁸ Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA.
• ⁹ Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 160 00, Prague, Czech Republic.
• ¹⁰ Innovative Molecules GmbH, Lipowsky Str. 10, 81373, Munich, Bavaria, Germany.
• ¹¹ PostEra Inc, 1 Broadway, Cambridge, MA, USA.
• ¹² Organic Chemistry, Department of Chemistry, Faculty of Sciences, University of Hamburg, Martin-Luther-King-Platz 6, Hamburg, Germany.
• ¹³ Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY, USA.
• ¹⁴ Baker Institute and Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA.
• ¹⁵ Fred Hutchinson Cancer Research Center, Vaccine and Infectious Diseases Division, Seattle, WA, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
• ¹⁶ Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore, MD, USA.
• ¹⁷ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ¹⁸ Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: [email protected].